The next-generation surgical device from Corcym was associated with consistent durability and positive safety data. For ...

How innovative technology is transforming heart disease treatment, enabling safer, minimally invasive procedures and tailored patient care for better outcomes. | Health ...

Corcym is touting positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve in its MANTRA ...

Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its ...

Yale Medicine orthopaedic surgeon Dr. Daniel Wiznia explains how this joint-preserving procedure works, how successful it is, ...

Many people think of periodontal disease as merely a problem within the mouth. They might think of symptoms like bleeding ...

Deborah Heart and Lung Center performed its first commercial implant of the Trilogy Transcatheter Heart Valve (THV) System ...

A research group at Kyoto University has announced the results of a nationwide data comparison of in-hospital outcomes for ...

The 46-year-old Princeton, New Jersey, dad was born with a defective aortic valve and had two heart surgeries as a child.

Boost ROI by targeting mitral, tricuspid and LAA closure innovations, expanding clinical indications, and pursuing startup acquisitions and imaging partnerships.Dublin, Oct. 06, 2026 (GLOBE NEWSWIRE) ...

Edwards Lifesciences (NYSE:EW) benefits from expanded Medicare coverage for TAVR and a structural heart deal, keeping the healthcare device maker in focus.

The natural history of symptomatic severe aortic stenosis (AS) heralds a poor prognosis—a paradigm that rightly drives valve ...